BioTelemetry, Inc. (NASDAQ:BEAT) Appoints Colin Hill to Board of Directors
GNS CEO Colin Hill has been named to the Board of Directors of BioTelemetry, Inc., the leading wireless medical technology company focused on the delivery of health information to improve quality of life and reduce cost of care. “Mr. Hill’s impressive leadership experience in machine learning in the precision medicine and managed care industries will […]
Health Data Management Spotlights GNS Medication Adherence Program With OmedaRx
Medication management has evolved from intuition-based treatments to population health, which emerged in the mid-1990s with a top-down, rules-based approach that treats individuals as hypotheticals, says Colin Hill, chairman and CEO of GNS Healthcare. But traditional methods to determine which patients to reach out to don’t target people who are at high risk of negative […]
CNBC’s Squawk Box Calls on GNS CEO Colin Hill to Understand Use of Big Data in Employee Wellness
Prompted by a Wall Street Journalarticle, CNBC’s Squawk Box Invited GNS CEO Colin Hill to explain the value of big data and machine learning-enabled employee wellness programs and to address concerns about privacy. Watch the segment here.
Wall Street Journal Article Highlights Role of Consumer Data in Employee Wellness Programs
Employee wellness firms and insurers are working with companies to mine data about the prescription drugs workers use, how they shop and even whether they vote, to predict their individual health needs and recommend treatments. Read the full article here.
Big Data Analytics Research Projects Target Cancer, Genomics
Several recently announced collaborations between academic research institutions and big data analytics vendors powering advanced discovery technologies will bring the power of big data to new studies that may have significant impacts on future therapies and treatments. With oncology and genomics in the spotlight, personalized medicine is poised to take a leap forward as researchers […]
Global Genomics Group (G3) and GNS Healthcare Report Preliminary Results of Largest-Ever Study Linking Biomarkers with Coronary Artery Disease
Study Applies GNS’s Causal Machine Learning to G3’s G3LOBAL DatabaseTM Study Demonstrates Proof of Concept of Approach with Identification of Known Coronary Disease-Associated Pathway ATLANTA, Ga. and CAMBRIDGE, Mass. – Jan. 8, 2016 – Global Genomics Group (G3), a life sciences company that leverages large-scale genomic and molecular disease profiles to develop life-changing diagnostics and therapeutics, […]
GNS Use of Machine Learning to Match Health Interventions to Individuals Featured by STAT
Health insurers are scooping up huge quantities of personal information in a bid to figure out when you’re likely to get sick —and to design interventions to keep you healthy. Read the full story here.
GNS Healthcare Secures $10M Series C Financing to Accelerate Development of New, Data-Driven Solutions at the Intersection of Precision Medicine and Population Health
New Investors Celgene Corporation, Alexandria Real Estate Equities, and Gi Global Health Fund LP Join Cambia Health Solutions, Heritage Provider Network, Mitsui CAMBRIDGE, Mass. – Dec. 8, 2015 – GNS Healthcare (GNS), a leading precision medicine company that applies causal machine learning technology to match health interventions to individual patients and discover new target intervention pathways, […]
BioIT World: GNS Healthcare Announces $10M Financing, MMRF Study Results
GNS Healthcare announced a $10M Series C financing round today. New investors in this round—Celgene Corporation, Alexandria Real Estate Equities, and Gi Global Health Fund LP—join previous investors including Cambia Health Solutions, California’s Heritage Provider Network, and Japan’s Mitsui & Co. U.S. subsidiary (“Mitsui USA”). GNS builds cloud-based big data solutions for precision medicine and […]
GenomeWeb: GNS Healthcare Lands $10M Series C Financing
NEW YORK (GenomeWeb) — GNS Healthcare has completed a $10 million Series C financing round, led by new investors including Celgene, Alexandria Real Estate Equities, and Gi Global Health Fund. The new investors joined prior investors in the round, including Cambia Health Solutions, Heritage Provider Network, and Mitsui USA. The firm said it would use […]